Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | HAAO | P46952 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | NOTUM | Q6P988 | 2/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | GABRP | O00591 | 1/20 | 0.41 |
| ▸ | GABRD | O14764 | 1/20 | 0.41 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.41 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.41 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.41 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.41 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8879082 | 0.98 | CYP1A2 (0.44) | CYP1A2HAAOALDH1A1KDM4EHPGD | |
| SCHEMBL27554808 | 0.89 | HAAO (0.41) | CYP1A2HAAOALDH1A1KDM4EHPGD | |
| SCHEMBL3392120 | 0.87 | TDP1 (0.48) | ALDH1A1KDM4EHPGDHSD17B10NOTUM | |
| SCHEMBL27693838 | 0.87 | GABRP (0.40) | CYP1A2HAAOALDH1A1KDM4EHPGD | |
| SCHEMBL27515105 | 0.86 | HAAO (0.39) | CYP1A2HAAOALDH1A1KDM4EHPGD | |
| SCHEMBL1988762 | 0.84 | CYP1A2 (0.61) | CYP1A2ALDH1A1KDM4EHPGDHSD17B10 | |
| SCHEMBL29445717 | 0.84 | CYP1A2 (0.61) | CYP1A2ALDH1A1KDM4EHPGDHSD17B10 | |
| SCHEMBL22989 | 0.84 | CYP1A2 (0.61) | CYP1A2ALDH1A1KDM4EHPGDHSD17B10 | |
| SCHEMBL195882 | 0.84 | CYP1A2 (0.44) | CYP1A2HAAOALDH1A1KDM4EHPGD | |
| SCHEMBL29400914 | 0.84 | CYP1A2 (0.44) | CYP1A2HAAOALDH1A1KDM4EHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 235 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1567470-B1 | HYDROGENATION OF BENZENE POLYCARBOXYLIC ACIDS OR DERIVATIVES THEREOF | EXXONMOBIL CHEM PATENTS INC (US) | 2013-06-05 | — | — | EP | claimed |
| US-5276127-A | Crosslinked polyester from polyfunctional acids and alcohols | MITSUBISHI RAYON COMPANY LTD. (JP) | 1994-01-04 | — | — | US | claimed |
| EP-0471302-A2 | Polyester resin for toner | MITSUBISHI RAYON CO., LTD (JP) | 1992-02-19 | — | — | EP | claimed |
| EP-1890992-B1 | AN ENRICHMENT PROCESS USING COMPOUNDS USEFUL IN A POLYESTER PROCESS | GRUPO PETROTEMEX SA DE CV (MX) | 2019-10-23 | — | — | EP | disclosed |
| EP-1888498-B1 | A PROCESS TO PRODUCE AN ENRICHMENT FEED | GRUPO PETROTEMEX SA DE CV (MX) | 2019-06-26 | — | — | EP | disclosed |
| EP-1888497-B1 | A PROCESS TO PRODUCE AN ENRICHED COMPOSITION THROUGH THE USE OF A CATALYST REMOVAL ZONE AND AN ENRICHMENT ZONE | GRUPO PETROTEMEX SA DE CV (MX) | 2019-04-17 | — | — | EP | disclosed |
| EP-2066612-B1 | A PROCESS TO PRODUCE AN ENRICHMENT FEED | GRUPO PETROTEMEX SA DE CV (MX) | 2018-08-01 | — | — | EP | disclosed |
| US-10029973-B2 | Optimized liquid-phase oxidation | GROPO PETROTEMEX, S.A. DE C.V. (MX) | 2018-07-24 | — | — | US | disclosed |
| US-20180072648-A1 | OPTIMIZED LIQUID-PHASE OXIDATION | GRUPO PETROTEMEX, S.A. DE C.V. (MX) | 2018-03-15 | — | — | US | disclosed |
| EP-2316566-B1 | Bubble column reactor for gas-liquid exchange reactions | GRUPO PETROTEMEX SA DE CV (MX) | 2017-11-22 | — | — | EP | disclosed |
| EP-1791800-B1 | OPTIMIZED LIQUID-PHASE OXIDATION | GRUPO PETROTEMEX SA DE CV (MX) | 2017-11-01 | — | — | EP | disclosed |
| CN-1191063-C | Antagonists for treatment of CD11/CD18 adhesion receptor mediated disorders | GENENTECH INC (US) | 2005-03-02 | — | — | CN | disclosed |
| EP-1338336-A1 | CATALYSTS COMPRISING N-SUBSTITUTED CYCLIC IMIDES AND PROCESSES FOR PREPARING ORGANIC COMPOUNDS WITH THE CATALYSTS | Daicel Chemical Industries, Ltd. (JP) | 2003-08-27 | — | — | EP | disclosed |
| US-20030013603-A1 | Catalyst comprising n-substituted cylic imides and processes for preparing organic compounds with the catalyst | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2003-01-16 | — | — | US | disclosed |
| CN-1342139-A | Serine protease inhibitors | GENENTECH INC (US) | 2002-03-27 | — | — | CN | disclosed |
| CN-1295471-A | Antagonists for treatment of CD11/CD18 adhesion receptor mediated disorders | GENENTECH INC (US) | 2001-05-16 | — | — | CN | disclosed |
| US-5276127-A | Crosslinked polyester from polyfunctional acids and alcohols | MITSUBISHI RAYON COMPANY LTD. (JP) | 1994-01-04 | — | — | US | disclosed |
| EP-0471302-A2 | Polyester resin for toner | MITSUBISHI RAYON CO., LTD (JP) | 1992-02-19 | — | — | EP | disclosed |
| CN-86103619-A | The preparation method of the bicyclic pyrazolidinones that 7-replaces | — | 1986-10-29 | — | — | CN | disclosed |
| CN-86102877-A | The method for preparing bicyclic pyrazolidinones | — | 1986-10-29 | — | — | CN | disclosed |